Skymab Biotherapeutics
Biotechnology Research • 
France • 11-20 Employees
Company overview
| Headquarters | France |
| Website | |
| SIC | 283 |
| Employees | 11-20 |
| Socials |
Key Contact at Skymab Biotherapeutics
Aiphi Nguyen
Co-Founder And Ceo
Skymab Biotherapeutics Email Formats
Skymab Biotherapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@skymab-biotherapeutics.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@skymab-biotherapeutics.com | 50% |
{first name}.{last name} | john.doe@skymab-biotherapeutics.com | 50% |
About Skymab Biotherapeutics
SKYMAB Biotherapeutics is a spin-off biotech company committed to the development of anti-gpcr antibody drug conjugates (adc). They combine technical knowhow in adc development with expertise in gpcr to create innovative tailored adcs that treat patients with high unmet medical needs in oncology.
Skymab Biotherapeutics revenue & valuation
| Annual revenue | $1,112,215 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Skymab Biotherapeutics has 7 employees across 5 departments.
Departments
Number of employees
United Kingdom
Spain
United States
Australia
Italy
Frequently asked questions
4.8
40,000 users
